Nobel Prizes usually honor research that is decades in the making, not recent technology.
QUICK FACTS:
- Researchers Katalin Kariko and Drew Weissman won the Nobel Medicine Prize for mRNA vaccine technology.
- In awarding the researchers, the Nobel committee broke the tradition of honoring research decades in the making, instead choosing to award a technology that has only been used for three years.
- According to a press release, the discoveries by the two Nobel Laureates “were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020.”
- “Through their groundbreaking findings, which have fundamentally changed our understanding of how mRNA interacts with our immune system, the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times,” the release adds.
- The “groundbreaking” research saved “millions of lives and prevented severe disease in many more,” the document claims. “Through their fundamental discoveries of the importance of base modifications in mRNA, this year’s Nobel laureates critically contributed to this transformative development during one of the biggest health crises of our time.”
- mRNA vaccines have been linked to many deaths, cancers, autoimmune disorders, and heart problems.
MRNA VACCINE INEFFECTIVE:
- Despite being hailed as a success by the Nobel committee, data show that mRNA vaccines are less than 36% effective against COVID-19 infection.
- According to a study in the medical journal Expert Review of Vaccines, Pfizer and Moderna’s mRNA COVID-19 vaccines are only 35.6% effective within 90 days of completion, dropping to just above 32% efficacy between 91 to 180 days post-vaccination.
- The study follows government declarations that the COVID-19 vaccine was 95% effective.
BACKGROUND:
- The development of Type 1 Diabetes has been linked to both mRNA and adjuvant COVID-19 vaccines, according to a case report published in the Journal of Korean Medical Science.
- The revelation comes after a woman without a history of diabetes developed “severe” diabetes symptoms after receiving a COVID-19 vaccine.
- The authors of the case report noted that while “several cases have been reported about new-onset FT1D” following mRNA vaccination, the publication is the first reported instance of new-onset Type 1 Diabetes following the administration of an “adjuvant” coronavirus vaccine.
- Adjuvant vaccines use aluminum hydroxide, a substance known to be toxic to human health.
